News

April 24, 2023 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved the newest addition to its feline portfolio — NexGard ® COMBO ...
Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) has approved the newest innovation from the trusted NexGard Brand of Products — NexGard PLUS (afoxolaner, moxidectin and ...
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continues to advance its pipeline in both Human Pharma and Animal Health expanding ...
With advancements in veterinary medicine, pet owners now have access to effective solutions, such as Boehringer Ingelheim's NexGard® COMBO for cats. This groundbreaking, easy-to-apply formula provides ...
Internal and external parasite threats have expanded beyond their traditional regions and seasons. Many tick species, for example, are now found in places that they didn't exist a decade ago ...
The NexGard ® COMBO formulation is the latest example of Boehringer Ingelheim building on its history of leadership in animal health to provide advanced, preventive animal healthcare and develop ...